Publications by authors named "N Ng"

Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death in the United States and globally. The Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population has often been studied as one homogenous cohort despite its heterogeneity. We aim to understand differences in treatment modality and mortality among AANHPI patients with early-stage HCC.

View Article and Find Full Text PDF

This study aimed to explore Singaporean fathers' perceived influence over their children's eating habits. A descriptive qualitative study design was used. Convenience sampling was used to recruit fathers of children aged 3-21 years old from a general paediatric outpatient clinic in a tertiary public hospital.

View Article and Find Full Text PDF

Purpose: To develop and pilot-test a novel training programme for nurses in acute care settings to improve their decision-making support skills, knowledge, attitudes, and confidence in conducting advance care planning (ACP).

Methods: A single-group repeated measures design was employed. This study was conducted in two phases.

View Article and Find Full Text PDF

Fine-mode particulate matter (PM) is a highly detrimental air pollutant, regulated without regard for chemical composition and a chief component of wildfire smoke. As wildfire activity increases with climate change, its growing continental influence necessitates multidisciplinary research to examine smoke's evolving chemical composition far downwind and connect chemical composition-based source apportionment to potential health effects. Leveraging advanced real-time speciated PM measurements, including an aerosol chemical speciation monitor in conjunction with source apportionment and health risk assessments, we quantified the stark pollution enhancements during peak Canadian wildfire smoke transport to New York City over June 6-9, 2023.

View Article and Find Full Text PDF

Unlabelled: Traumatic brain injury (TBI) and subsequent neurodegeneration is partially driven by chronic inflammation both locally and systemically. Yet, current clinical intervention strategies do not mitigate inflammation sequalae necessitating the development of innovative approaches to reduce inflammation and minimize deleterious effects of TBI. Herein, a subcutaneous formulation based on polymer of alpha-ketoglutarate (paKG) delivering glycolytic inhibitor PFK15 (PFKFB3 inhibitor, a rate limiting step in glycolysis), alpha-ketoglutarate (to fuel Krebs cycle) and peptide antigen from myelin proteolipid protein (PLP139-151) was utilized as the prophylactic immunosuppressive formulation in a mouse model of TBI.

View Article and Find Full Text PDF